| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/30/2002 | CA2725716A1 Method of making 5, 10, 15, 20-tetrakis(carboxyphenyl) porphine solutions and compositions thereof |
| 05/30/2002 | CA2541946A1 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 05/30/2002 | CA2434760A1 Differentiated cells suitable for human therapy |
| 05/30/2002 | CA2431947A1 Composition comprising an imexon or derivatives thereof and lipids |
| 05/30/2002 | CA2430190A1 Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
| 05/30/2002 | CA2430100A1 Antiangiogenic agents |
| 05/30/2002 | CA2430037A1 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 05/30/2002 | CA2429976A1 Polysaccharide compound having immune stimulating activity |
| 05/30/2002 | CA2429817A1 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 05/30/2002 | CA2429647A1 Use of thienopyrimidines |
| 05/30/2002 | CA2429645A1 Use of pyrazolo[4,3-d]pyrimidines |
| 05/30/2002 | CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | CA2429624A1 Compositions for adhesion prevention |
| 05/30/2002 | CA2429618A1 Rhinologically active substances |
| 05/30/2002 | CA2429605A1 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | CA2429579A1 Truncated cd200 |
| 05/30/2002 | CA2429570A1 Pyrimidine derivatives |
| 05/30/2002 | CA2429516A1 As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation |
| 05/30/2002 | CA2429480A1 Ophthalmological preparations |
| 05/30/2002 | CA2429442A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | CA2429383A1 Selective dopamine d4 receptor agonists for treating sexual dysfunction |
| 05/30/2002 | CA2429368A1 Production of stilbenes in transgenic plants and the method of producing thereof |
| 05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | CA2429326A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors |
| 05/30/2002 | CA2429313A1 Novel sulfonamide-substituted pyrazolopyridine derivatives |
| 05/30/2002 | CA2429310A1 Repinotan kit |
| 05/30/2002 | CA2429309A1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 05/30/2002 | CA2429260A1 Medicinal compositions comprising cs-866 and a diuretic |
| 05/30/2002 | CA2429257A1 Antidiabetic compositions containing a biguanide and a sulfonamide |
| 05/30/2002 | CA2428902A1 Compositions having comfrey and methods for reducing retinoid-induced skin irritation |
| 05/30/2002 | CA2428634A1 Cosmetic method of treating skin |
| 05/30/2002 | CA2428470A1 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage |
| 05/30/2002 | CA2428461A1 Imidazolone derivatives for the treatment of viral diseases |
| 05/30/2002 | CA2428459A1 Novel compounds for use as hiv protease inhibitors |
| 05/30/2002 | CA2428386A1 Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage |
| 05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | CA2427931A1 Indole derivatives and medical applications thereof |
| 05/30/2002 | CA2427661A1 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/30/2002 | CA2427444A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | CA2427334A1 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | CA2427330A1 Inhibitors of abc drug transporters at the blood-brain barrier |
| 05/30/2002 | CA2427284A1 Antiinflammation agents |
| 05/30/2002 | CA2427184A1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 05/30/2002 | CA2426929A1 Treatment of osteoporosis |
| 05/30/2002 | CA2426601A1 Cyanoguanidine prodrugs |
| 05/30/2002 | CA2363935A1 Therapy for andropause using estrogen agonists/antagonists and testosterone |
| 05/29/2002 | EP1209166A1 Novel a-500359 derivatives |
| 05/29/2002 | EP1209158A1 Substituted beta-carbolines |
| 05/29/2002 | EP1209157A1 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
| 05/29/2002 | EP1208855A1 Novel embolizing compositions |
| 05/29/2002 | EP1208850A1 Pastes with the sustained release of osteogenesis promoter |
| 05/29/2002 | EP1208848A1 Stable lactase compositions |
| 05/29/2002 | EP1208847A2 Pharmaceutical compositions for treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin A and 40-O(2-hydroxyethyl)-rapamycin |
| 05/29/2002 | EP1208844A1 Therapeutic agent for mastitis of livestock and method for treating mastitis using the same agent |
| 05/29/2002 | EP1208843A1 Soft capsules |
| 05/29/2002 | EP1208842A2 Regulation of the immune system |
| 05/29/2002 | EP1208841A1 Neuropathy remedies |
| 05/29/2002 | EP1208840A2 Combination of fluorouracil and a methylol transfer agent for the treatment of tumor metastases and cancer |
| 05/29/2002 | EP1208839A1 Chelate compound for treating Helicobacter pylori infections |
| 05/29/2002 | EP1208838A2 Pure S(+)isomer fluoxetine |
| 05/29/2002 | EP1208751A1 Natural physiologically active substances efficacious against fish parasites and fish feeds containing the substances |
| 05/29/2002 | EP1208701A2 Communications system |
| 05/29/2002 | EP1208381A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 05/29/2002 | EP1208380A2 Cancer associated antigens and uses therefor |
| 05/29/2002 | EP1208242A1 Antisense modulation of pepck-mitochondrial expression |
| 05/29/2002 | EP1208234A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids |
| 05/29/2002 | EP1208228A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 05/29/2002 | EP1208227A2 Methods for diagnosing, preventing and treating developmental disorders due to a combination of genetic and environmental factors |
| 05/29/2002 | EP1208219A1 Synthesis of biologically active compounds in cells |
| 05/29/2002 | EP1208218A2 Methods and compositions for delivery of pharmaceutical agents |
| 05/29/2002 | EP1208217A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
| 05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 05/29/2002 | EP1208195A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1208191A1 13 human colon and colon cancer associated proteins |
| 05/29/2002 | EP1208140A1 Rapidly decomposing chitosan-based pellets |
| 05/29/2002 | EP1208133A1 Copolymers for the transfer of nucleic acids to the cell |
| 05/29/2002 | EP1208113A2 17beta-acyl-alpha-propynyl-11beta-(cyclic amino)aryl steroids and their derivatives having antagonist hormonal properties |
| 05/29/2002 | EP1208110A1 Antisense modulation of focal adhesion kinase expression |
| 05/29/2002 | EP1208104A2 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 05/29/2002 | EP1208103A2 Reverse-turn mimetics and methods relating thereto |
| 05/29/2002 | EP1208101A1 Vitronectin receptor antagonists useful for the treatment of strokes |
| 05/29/2002 | EP1208100A1 Selective antagonists of a2b adenosine receptors |
| 05/29/2002 | EP1208099A1 4,5-diaryloxazole compounds with prostaglandin i2 (pgi2) agonistic activity |
| 05/29/2002 | EP1208097A2 Substituted oxoazaheterocyclyl compounds |
| 05/29/2002 | EP1208096A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 05/29/2002 | EP1208095A1 Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes |
| 05/29/2002 | EP1208092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/29/2002 | EP1208089A2 Diazocin-dione derivatives and their use as tryptase inhibitors |
| 05/29/2002 | EP1208088A2 Fluorene derivatives as integrin inhibitors |
| 05/29/2002 | EP1208086A1 Benzamide formulation with histone deacetylase inhibitor activity |
| 05/29/2002 | EP1208085A2 Benzanilides as potassium channel openers |
| 05/29/2002 | EP1207909A2 Method for coupling molecules |
| 05/29/2002 | EP1207908A1 Method of treating body insect infestation |
| 05/29/2002 | EP1207907A2 Compositions for treating viral infections, and methods therefor |
| 05/29/2002 | EP1207905A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 05/29/2002 | EP1207891A2 Use of a low molecular weight sulphated polysaccharide to obtain a medicine with antithrombotic activity |
| 05/29/2002 | EP1207890A2 Antiviral prodrugs |
| 05/29/2002 | EP1207888A2 Use of paclitaxel and of steroid derivatives as aromatase inhibitors for the treatment of cancer |